(Q50794075)
Statements
Evaluation of ticagrelor pharmacodynamic interactions with reversibly binding or non-reversibly binding P2Y(12) antagonists in an ex-vivo canine model. (English)
1 reference
Anna Ravnefjord
1 reference
Jessika Weilitz
1 reference
Britt-Marie Emanuelsson
1 reference
J J J van Giezen
1 reference
19 August 2012
1 reference
130
1 reference
4
1 reference
622-628
1 reference